publication venue for
- Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study. 2025
- Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial.. 10. 2025
- Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial.. 8. 2023
- Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA.. 6. 2021
- Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study.. 4. 2019
- Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.. 1. 2016
- A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease. 2021
- Oesophageal manometry with a solid test meal: ready for prime time? 2017
- Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? - Authors' reply. 2024
- Joint statement in support of hepatitis C human challenge studies. 2023
- The intestinal barrier: a pivotal role in health, inflammation, and cancer. 2025
- Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. 2023
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. 2023
- Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. 2022
- Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. 2022